Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,048.00
Bid: 12,048.00
Ask: 12,050.00
Change: 696.00 (6.13%)
Spread: 2.00 (0.017%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Vaccine manufacturing is lumpy, supply not as good as hoped, UK says

Mon, 18th Jan 2021 08:16

* UK says AstraZeneca slower than hoped

* UK says Pfizer changes may lead to delays

* UK is vaccinating 140 people per minute on average
(Recasts headline and lead with manufacturing issues)

By Guy Faulconbridge and Kate Holton

LONDON, Jan 18 (Reuters) - Britain's vaccine rollout is
limited by a "lumpy" manufacturing process with production
changes by Pfizer and a delay by AstraZeneca
that could lead to brief supply disruption, Vaccine Deployment
Minister Nadhim Zahawi said on Monday.

The United Kingdom, which has the world's fifth worst
official COVID-19 death toll, is racing to be among the first
major countries to vaccinate its population - seen as the best
way to exit the pandemic and get the economy going again.

The United Kingdom has vaccinated 3,857,266 people with a
first dose and 449,736 with a second dose. On vaccines
administered per 100 people, the United Kingdom is fourth in the
world after Israel, the United Arab Emirates and Bahrain.

Zahawi told LBC radio that the United Kingdom was hoping for
2 million vaccines a week from AstraZeneca but that
those numbers will not be reached until mid February. Still, he
said the UK was on course to hit its rollout targets.

"It's been a bit lumpy," Zahawi said of vaccine manufacture.

Pfizer will temporarily reduce its deliveries to Europe of
its vaccine against COVID-19 while it upgrades its production
capacity.

"There's bound to be delays. Any new manufacturing process
has challenges at the outset, it is lumpy, it begins to
stabilise and get better and better week in, week out," Zahawi
told the BBC.

"The Pfizer BioNTech vaccine is a messenger RNA chemical,
difficult chemical to manufacture, very very challenging but
they're doing really well, they want to do more which is why
they're reconfiguring to add volume to the whole world," Zahawi
said.

"That could delay supply but I'm confident we can meet our
target."

VACCINE HOPES

Mass COVID-19 vaccines are seen as the best way to exit the
pandemic which has killed more than 2 million people, wiped out
trillions of dollars in economic output and upended normal life
for people across the world.

The United Kingdom is vaccinating 140 people per minute
against COVID-19 on average.

"It is going well, we're vaccinating on average 140 people,
that's first jab, literally a minute. That's the average so some
areas are doing better," Zahawi told Sky.

Britain is currently rolling out the vaccine to the most
vulnerable first, starting with those who are in care homes or
over 80 years of age. In areas where a majority of over 80s have
been offered a vaccine, letters are going out to the over 70s
and those who are clinically extremely vulnerable.

Zahawi said a 24-hour vaccine offering would begin to be
piloted in London by the end of the month.

Essential workers such as teachers, the police and shop
assistants could move to the top of the list for a vaccine once
all those over 50 have been offered a shot, Zahawi said.

"Teachers, police officers, shop workers, those who through
no fault of their own other than the work that they do may come
into contact with the virus in much greater volume, should be
top of the list," Zahawi told Times Radio.
(Reporting by Guy Faulconbridge and Kate Holton; editing by
Sarah Young, Paul Sandle and Philippa Fletcher)

More News
Today 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
Today 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
Today 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
Today 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
Today 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.